Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jessica Darlington-Brown"'
Autor:
Karen Canfell, Michael Caruana, Val Gebski, Jessica Darlington-Brown, Stella Heley, Julia Brotherton, Dorota Gertig, Chloe J Jennett, Annabelle Farnsworth, Jeffrey Tan, C David Wrede, Philip E Castle, Marion Saville
Publikováno v:
PLoS Medicine, Vol 14, Iss 9, p e1002388 (2017)
BACKGROUND:Using primary human papillomavirus (HPV) testing for cervical screening increases detection of high-grade cervical intraepithelial neoplastic lesions and invasive cancer (cervical intraepithelial neoplasia grade 2+ [CIN2+]) compared to cyt
Externí odkaz:
https://doaj.org/article/ecf50958813248abb0f24a7e6332e04c
Autor:
Paul Grogan, Harriet Hui, Susan Yuill, Karen Canfell, Marion Saville, Julia M.L. Brotherton, Suzanne M. Garland, Rachel Skinner, Suzanne Hughes, Jonathan Carter, Kate T. Simms, Lara Roeske, Louiza S. Velentzis, Deborah Bateson, Katherine Butler, Rebecca Guy, Michaela T. Hall, Megan Smith, Adam Keane, Philip E. Castle, Ian H. Frazer, Stella Heley, Bruce K. Armstrong, Alison Brand, Jessica Darlington-Brown, Marc Arbyn, Jie-Bin Lew, Ian Hammond, James Killen
Publikováno v:
Gynecologic oncology. 152(3)
Objective Australia's HPV vaccination and HPV-based cervical screening programs are changing the landscape in cervical cancer prevention. We aim to identify areas which can make the biggest further impact on cervical cancer burden. This protocol desc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60b15569e77ee515c48c2fa8e41b75db
https://pubmed.ncbi.nlm.nih.gov/30876490
https://pubmed.ncbi.nlm.nih.gov/30876490
Autor:
Freddy Sitas, Karen Canfell, Dianne L. O'Connell, Jessica Darlington-Brown, Sam Egger, Emily Banks, Louiza S. Velentzis, Huilan Xu
Background Human papillomavirus (HPV) vaccines protect against HPV types 16/18, but do not eliminate the need to detect pre-cancerous lesions. Australian women vaccinated as teenage girls are now entering their mid-thirties. Since other oncogenic HPV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26e50d555ee438e5a26193e8a93f10fb
https://hdl.handle.net/2123/30520
https://hdl.handle.net/2123/30520
Autor:
Michael Caruana, Marion Saville, Julia M.L. Brotherton, Val Gebski, Philip E. Castle, Karen Canfell, Jessica Darlington-Brown, Stella Heley
Publikováno v:
BMJ Open
Introduction Australia’s National Cervical Screening Program (NCSP) currently recommends 2-year cytology in women aged 18–69 years. Following a review of the NCSP prompted by the implementation of human papillomavirus (HPV) vaccination, the progr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63673ed2a7a3647d939a726ad0884af8
http://europepmc.org/articles/PMC5829592
http://europepmc.org/articles/PMC5829592
Autor:
Sam Egger, Karen Canfell, Emily Banks, Dianne L. O'Connell, Louiza S. Velentzis, Freddy Sitas, Jessica Darlington Brown
Publikováno v:
Vaccine. 33:2387-2394
Background Australia commenced a publically-funded, National Human Papillomavirus (HPV) Vaccination Program in 2007 with a two year catch-up phase for females aged 12–26 years. Objective To identify the factors associated with the uptake of the HPV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::727e63305d659ce043f10a745d74658f
https://doi.org/10.1016/j.vaccine.2015.01.024
https://doi.org/10.1016/j.vaccine.2015.01.024
Autor:
Annabelle Farnsworth, Marion Saville, Julia M.L. Brotherton, Dorota M. Gertig, C. David Wrede, Chloe J Jennett, Stella Heley, Jessica Darlington-Brown, Michael Caruana, Karen Canfell, Jeffrey Tan, Val Gebski, Philip E. Castle
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 14, Iss 9, p e1002388 (2017)
PLoS Medicine, Vol 14, Iss 9, p e1002388 (2017)
Background Using primary human papillomavirus (HPV) testing for cervical screening increases detection of high-grade cervical intraepithelial neoplastic lesions and invasive cancer (cervical intraepithelial neoplasia grade 2+ [CIN2+]) compared to cyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c3d3f50666cd9a8e87f86eb988ee9e1
https://pubmed.ncbi.nlm.nih.gov/28926579
https://pubmed.ncbi.nlm.nih.gov/28926579
Autor:
Freddy Sitas, Sam Egger, Ian H. Frazer, Rohit Sinha, Louiza S. Velentzis, Dianne L. O'Connell, Emily Banks, Karen Canfell, Jessica Darlington-Brown
Publikováno v:
BMC Infectious Diseases
Background Australia commenced human papillomavirus (HPV) vaccination in 2007, with a two-year catch-up to the age of 26; catch-up cohorts are thus now entering their thirties. Plans for monitoring vaccine impact involve pre- and post-vaccination ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e372a5ce37127e23601d1dbd577f1cc